Immunotherapy drugs called immune checkpoint inhibitors (ICIs) have changed treatment options for lung cancer. By removing blocks on immune cells, ICIs help the body recognize and attack cancer. But this same immune activation can affect healthy tissue in the gut. The result is a condition called immune-related colitis, which causes diarrhea ranging from mild to severe. A study of 607 patients with advanced non-small cell lung cancer found that 13.8% experienced immune-mediated diarrhea or colitis during ICI treatment, according to a multidisciplinary management study published in PMC.
Two supportive compounds have been studied for gut protection and recovery: black seed oil (from Nigella sativa, containing the active compound thymoquinone) and multi-strain probiotics. They don’t replace corticosteroid treatment for moderate-to-severe colitis. Researchers are studying whether both can reduce gut inflammation and support microbiome health. This article explains what research shows about each, including doses from published studies.
| Feature | Black Seed Oil (Thymoquinone) | Multi-strain Probiotic |
|---|---|---|
| Active compound | Thymoquinone from Nigella sativa | Lactobacillus reuteri, L. rhamnosus, Bifidobacterium species |
| Dose in oncology studies | Varies by formulation; no standard human dose established for ICI-related diarrhea | 2.7 billion to 30 billion CFU per day, depending on trial design |
| Evidence base | Preclinical (animal and cell models); limited human GI data | Phase II-III trials in chemo-related diarrhea; preclinical data for ICI colitis |
| Proposed gut mechanism | Reduces TNF-alpha and IL-6; may suppress JNK signaling in gut epithelium | Restores microbiome balance; may suppress ILC3 immune cells at the gut wall |
| Key safety note | May affect cytochrome P450 enzyme pathways; ICI drug interaction unstudied in humans | Generally tolerated; caution advised if neutropenic or on corticosteroids |
Sources: Nigella sativa GI review, PubMed; Thymoquinone gut epithelial study, PMC; Phase III probiotic trial in colorectal cancer, PMC; Lactobacillus reuteri and ICI colitis, PMC.
What Immunotherapy Does to the Gut
Immune checkpoint inhibitors block proteins like PD-1, PD-L1, and CTLA-4. These proteins act as brakes on immune cells. When ICIs block them, the immune system becomes more active against cancer. That same activation can also spread to the lining of the colon and small intestine, causing inflammation. Doctors call this immune-related colitis.
A meta-analysis of ICI trials in lung cancer found that diarrhea and colitis occurred more often than with placebo. Rates varied by drug type, combination regimen, and dosing. This systematic review and meta-analysis, published in PMC, combined data from multiple randomized trials across lung cancer populations. The data showed higher colitis risk with ICI use.
Before attributing any diarrhea to the immune system, your oncology team will first rule out other causes. Infectious diarrhea – from bacteria, Clostridioides difficile, or viruses – requires different treatment. A comprehensive PMC review on ICI-induced colitis notes that doctors use a full differential diagnosis, including stool cultures and endoscopy when needed, before attributing symptoms to immunotherapy.
Grading Immune-Related Diarrhea
Doctors grade immune-related diarrhea using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE). The grade determines whether immunotherapy continues and what treatment is started.
- Grade 1: Up to 3 extra bowel movements per day above baseline. Immunotherapy typically continues. Management includes oral fluids and dietary adjustments.
- Grade 2: 4 to 6 extra bowel movements per day. Doctors pause immunotherapy. According to the ASCO Guideline Update on immune-related adverse events, doctors treat Grade 2 colitis with corticosteroids starting at 1 mg per kilogram per day of prednisone or an equivalent steroid.
- Grade 3: More than 6 extra bowel movements per day, or signs of bleeding or bowel wall complications. Doctors hold or stop immunotherapy. Doctors may add biologic agents such as infliximab if steroids don’t work within 2 to 3 days.
- Grade 4: Life-threatening complications. Doctors permanently stop immunotherapy. You need urgent hospitalization and intensive management.
Use black seed oil and probiotics for Grade 1 situations or to help you recover after medical treatment has controlled an acute episode. They don’t replace corticosteroid therapy at Grade 2 or above. Talk with your oncologist about timing and whether a supplement is right for your situation before you start anything.
Black Seed Oil: What the Research Shows
Black seed oil comes from the seeds of Nigella sativa, a plant examined in both traditional and modern research. Its main bioactive compound, thymoquinone, has been studied for anti-inflammatory properties in several gut-related contexts.
A 2016 PubMed review covering the gastrointestinal effects of Nigella sativa found that both the whole seed oil and extracted thymoquinone may reduce gut inflammation, improve motility, and support mucosal protection. The authors examined multiple pro-inflammatory pathways relevant to gut lining health. Most data in that review came from animal studies, with limited human observations. No standard dose for immunotherapy-related colitis was identified.
A 2022 PMC study found that Nigella sativa oil helped protect colon structure and reduced levels of the inflammatory markers TNF-alpha and IL-2 in an animal model of intestinal toxicity, as documented in research on Nigella sativa oil, mucin expression, and microbiota integrity. These inflammatory markers overlap with the pathways activated in ICI-related colitis, though researchers didn’t test it in immunotherapy patients.
A 2025 PMC study examined thymoquinone specifically in gut epithelial injury. The study found that thymoquinone may reduce gut epithelial damage by suppressing the JNK signaling pathway, which is involved in cell stress and inflammation. They tested this in cell and animal models. No one has published human trial data on thymoquinone specifically in ICI-related colitis.
No standard dose of black seed oil for immunotherapy-related diarrhea exists. Published gut research shows doses vary by formulation and population. BSOFit Black Seed Oil is one option that lists thymoquinone from Nigella sativa as its active compound. Talk with your oncologist or pharmacist about the specific dose and timing before you start any black seed oil product during cancer treatment.
Probiotics: Evidence in Cancer-Related Gut Disturbance
Probiotics are live bacterial cultures that may help restore balance in the gut microbiome. In cancer treatment, doctors have linked the gut microbiome to how well treatment works and to immune-related side effects. Researchers are still in early stages of studying this in people receiving ICIs.
A preclinical PMC study found that Lactobacillus reuteri reduced immune checkpoint blockade-associated colitis in animal models by suppressing group 3 innate lymphoid cells (ILC3s) – a specific immune cell type that contributes to gut inflammation triggered by ICIs. This is one of the most direct pieces of preclinical evidence linking a named probiotic strain to ICI-triggered gut inflammation. Researchers haven’t published human trial confirmation yet.
In a phase III randomized trial in colorectal cancer patients receiving irinotecan-based chemotherapy, researchers tested a combination of Bifidobacterium BB-12 and Lactobacillus rhamnosus LGG at approximately 2.7 billion CFU (2.7 x 10^9 colony-forming units) per day for 6 weeks. While this trial examined chemotherapy-related diarrhea rather than ICI-related colitis, it provides verified dose context from a rigorously designed cancer-specific trial.
A clinical trial registered at ClinicalTrials.gov under identifier NCT06508034 is actively studying whether probiotics can prevent immunotherapy-induced colitis in patients receiving checkpoint inhibitors. Until ICI-specific trials produce results, probiotic use remains supportive and investigational rather than standard practice.
Strain specificity matters. Lactobacillus reuteri and Lactobacillus rhamnosus are different, and commercial probiotic products vary widely in their strains and CFU counts. Research doses for cancer-related diarrhea trials range from about 2.7 billion to 30 billion CFU per day depending on the study. Ask your pharmacist to check any specific product against the strains and doses used in clinical research before you buy it.
If your lung cancer treatment also involves integrative compounds alongside immunotherapy, the article on quercetin and green tea during lung cancer immunotherapy covers additional compounds being studied in the ICI setting.
Using Both Together: Key Considerations
Black seed oil and probiotics work through different pathways in the gut. Thymoquinone targets pro-inflammatory signaling molecules. Probiotics target microbiome composition and gut immune cell behavior. In theory, these approaches may be complementary. However, no published human trial has tested this specific combination in ICI-treated lung cancer patients, so researchers don’t know how they interact.
Practical points if you are considering both:
- Don’t add supplements during an active Grade 2 or higher colitis episode without your oncologist’s approval. Medical management with corticosteroids and, if needed, biologics comes first at those grades.
- If combining probiotics with corticosteroid treatment for colitis, ask your pharmacist about best timing. Steroids alter gut environment and microbiome balance in ways that may affect how probiotics perform.
- If you use black seed oil, know that thymoquinone may affect cytochrome P450 enzyme pathways involved in drug metabolism. This matters if you take multiple medications alongside immunotherapy.
- Tell your full care team about both products. Keep a written log of any supplements, including dose and start date, and bring it to every oncology appointment.
For context on how similar gut-protective compounds have been studied in a related cancer setting, the article on Black Seed Oil and Probiotics for Colorectal Chemo Diarrhea covers the evidence base in colorectal cancer patients experiencing treatment-related diarrhea – a useful comparison given the overlapping compounds.
Practical Steps During Recovery
Regardless of which supportive approach your care team approves, basic self-care steps help manage symptoms and give your oncologist the tracking data needed to make grading decisions.
- Hydrate with electrolytes. Diarrhea causes rapid fluid and electrolyte loss. Oral rehydration solutions with sodium and potassium work better than plain water during active episodes.
- Follow a low-residue diet. Foods such as plain white rice, cooked carrots, bananas, and plain protein sources reduce bowel stimulation. Ask your oncology dietitian for a specific meal plan.
- Track bowel movements daily. Count and record the number of loose stools per day. This data directly informs NCI grading and your oncologist’s next treatment decision.
- Know the red flags. Blood or mucus in stool, fever, or severe cramping with diarrhea require calling your care team right away. These symptoms may indicate Grade 3-4 colitis, which is a medical emergency.
- Do not mask symptoms. Avoid loperamide (Imodium) or similar drugs without oncologist guidance during active ICI treatment. Masking symptoms can delay necessary medical escalation.
Patients also managing diarrhea from targeted therapy agents used in lung cancer may find additional detail in the cabozantinib toxicity management guide for lung cancer caregivers, which covers GI side effects including diarrhea in that treatment context.
Choosing a Quality Formulation
If your oncologist has approved black seed oil as a supportive supplement during or after immunotherapy, product quality matters. Thymoquinone content varies between formulations. You can compare nutraceutical formulations and bring specific products to your pharmacist for review before starting.
If you take prescription medications, or if you are pregnant or breastfeeding, talk with a doctor before adding any supplement. This article is for information only, not medical advice. Always talk with your oncologist or care team about your specific situation.
